Context. Contraception is increasingly used as a management technique to reduce fertility in wildlife populations; however, the feasibility of contraceptive formulations has been limited until recently because they have required multiple treatments to achieve prolonged infertility.
Introduction
The overabundance of wildlife is an ongoing problem, with many pest species increasing to numbers that become detrimental to both the environment and other wildlife species (e.g. elephants (Loxodonta africana): Whyte et al. 1998; white-tailed deer (Odocoileus virginianus) : Warren 1997 ; feral horses (Equus caballus) : Wagner 1983 ; Canadian geese (Branta canadensis): Conover and Chasko 1985) . Traditionally, populations of overabundant wildlife were controlled by lethal control or permanent removals. However, mortality manipulation can cause increased population growth as a result of compensatory growth (Garrott and Taylor 1990; Kirkpatrick and Turner 1991) , changes to animal movements (Henderson et al. 2000) and public objections (Stout et al. 1997; Lauber et al. 2007) . Consequently, non-lethal methods of control, usually involving fertility manipulations, are becoming increasingly advocated when traditional culling methods are impractical or undesirable (Kirkpatrick 2007) .
Contraception has become a relatively widely used non-lethal technique to manage overabundant wildlife populations and is usually considered a more humane and politically acceptable long-term approach to population control because animals remain in the wild and most treatments are reversible (Oogjes 1997; Kirkpatrick 2007) . In particular, immunocontraception, which uses an animal's own immune system to inhibit fertility, has been tested extensively in many wildlife species to prevent pregnancy, particularly formulations that block oestrous cycling or fertilisation through GnRH immunisation (Miller et al. 2000a; Baker et al. 2002; Killian et al. 2006; Conner et al. 2007) or treatment with porcine zona pellucida (PZP) (Kirkpatrick et al. 1992 Turner et al. 1996 Turner et al. , 1997 Turner et al. , 2001 Turner et al. , 2007 Fayrer-Hosken et al. 2000; Miller et al. 2000b; Delsink et al. 2002; Naugle et al. 2002; Walter et al. 2002; Rutberg et al. 2004; Lane et al. 2007) . While biologically effective, contraceptive formulations also need to be practical and cost-effective for management, preferably using only a single dose.
In the USA, feral horses are federally managed and protected on public lands under the Wild Free-Roaming Horse and Burro Act of 1971 and continue to overpopulate rangelands where they can have a negative impact on grasslands, riparian areas, soils and other wildlife species (Rogers 1990; Brussard 2000, 2004; Levin et al. 2002; Zalba and Cozzani 2004; Beever and Herrick 2006) . Despite this trend, lethal control is largely unacceptable to the public. Past-management techniques have focused on the 'round-up and adopt-out' method, although there have been concerns about the efficacy of these programs and their impact on animal welfare (Kirkpatrick 2007) . Contraceptive formulations have been extensively researched in feral horses (PZP; Kirkpatrick et al. 1990 Kirkpatrick et al. , 1996 Turner et al. 1997 Turner et al. , 2001 Turner et al. , 2007 and show promise for population control that may be more cost effective than removals over the long-term (Bartholow 2007) . However, there is a need for a formulation that lasts for more than 1 year without the need for boosters or multiple injections so as to decrease the costs and stress associated with multiple gathers.
Concerns have been raised over the potential side effects of contraceptive treatments (see Nettles 1997) , yet there has been little research conducted that addresses side effects in comparison to efficacy studies (Gray and Cameron 2010) . Most research on side effects has focused on breeding behaviour and body condition of treated females. For example, several studies have shown that contraceptives alter breeding behaviour of females, which results in a lengthened breeding season and later offspring birth dates (McShea et al. 1997; Heilmann et al. 1998; Miller et al. 2000b ). However, a study on PZP showed no difference in the month that foals were born to females where contraception was waning (Kirkpatrick and Turner 2003) . Several studies have also reported increased body condition of treated females in wild species (McShea et al. 1997, Turner and . Although increases to body condition can be desirable, they could have an impact on offspring sex ratios because females that experience increased condition tend to have more sons (Cameron 2004) . Regardless of treatment, side effects should be studied on managed species to minimise impacts to behaviour, physiology and population health.
We tested efficacy of contraceptive formulations in freeroaming feral horses in the Virginia Range in Nevada. We used two different formulations that were developed to reduce fertility over multiple years following one vaccination. The first formulation, SpayVac ® , is a liposome-encapsulated porcine zona pellucida (PZP) that acts to prevent pregnancy by blocking fertilisation by targeting the zona pellucida of the ovum. A single dose can last for several years (Brown et al. 1997 ). This contrasts with other PZP formulations that require multiple doses to achieve multiple years of infertility (Turner et al. 2001 , although a vaccination that lasts between 2 and 3 years has been developed recently (Turner et al. 2007 ). SpayVac has been successfully used as a single-dose, multi-year contraceptive in fallow deer (Dama dama) (Fraker et al. 2002) , white-tailed deer (Hernandez et al. 2006) , grey seals (Halichoerus grypus) (Brown et al. 1997 ) and captive feral horses . The second formulation, GonaCon-BÔ, is a gonadotrophin-releasing hormone (GnRH) vaccine that consists of synthetic GnRH conjugated with a blue mollusk protein. Once injected, antibodies are produced and bind to endogenous GnRH. The antibody-GnRH complex is too large to diffuse from the blood into the anterior pituitary, resulting in a significant reduction in the production of follicle-stimulating hormone (FSH) and luteinising hormone (LH), thereby preventing ovulation . This formulation has been effective in white-tailed deer (Miller et al. 2000a) , bison (Bison bison) (Miller et al. 2004) , feral swine (Sus scrofa) (Killian et al. 2006; Massei et al. 2008 ) and captive feral horses . Both formulations alone would not elicit a large or long-term response, thus AdjuVacÔ, an oilbased adjuvant (a non-specific immune stimulant), was used to increase the immune response. Our main objectives were to test two contraceptive formulations in free-roaming horses to determine (1) the effectiveness of these contraceptives to induce infertility up to 3 years after administration of a single dose and (2) potential side effects on foal survival, birth sex ratio and birthing season.
Materials and methods

Study site and animals
The study was conducted in the Virginia Range, south-west of Reno, Nevada, USA. The range is~145 000 ha of private land, with a small percentage developed for houses and industry. The mountain range consists of sagebrush (Artemesia tridentata) communities, with groups of pine (Pinus jeffreyi, Pinus monophylla) and juniper (Juniperus osteosperma) at higher elevations. Other common plant species include bluegrass (Poa secunda), rabbitbrush (Chrysothamnus nauseosus), bitterbrush (Purshia tridentata) and cheatgrass (Bromus tectorum). In addition to feral horses, other ungulates in the range included mule deer (Odocoileus hemionus) and pronghorn (Antilocapra americana). The predators in the range were mountain lions (Puma concolor), bobcats (Lynx rufus) and coyotes (Canis latrans).
The population of feral horses is classified as estray by the Nevada Department of Agriculture because they range on private property and are therefore not protected under the Wild Free-Roaming Horse and Burro Act of 1971. Consequently, they are legally defined as feral livestock, and the Nevada Department of Agriculture is responsible for the management of the population. The population size has fluctuated from >1200 in 2004 to~1400 in 2009, and is currently being managed with the use of both removals and contraception. The long-term management goal is to decrease population size and stabilise population growth.
Vaccine types and treatment protocol
We selected a treatment site for both ease of capture, the large number of horses present in the valley and permission from private land owners. Horses were rounded up with a helicopter on 15 and 16 June 2005. Horses were held in purpose-built yards and restrained in a hydraulic squeeze chute for treatment. We treated every female >1 year of age with 1-mL intramuscular dose in the left side of the neck in the serratus ventralis muscle with one of the following four treatments: (1) GonaCon-B (NWRC, Fort Collins, CO, USA) (n = 20), (2) SpayVac (ImmunoVaccine Technologies (IVT), Halifax, Nova Scotia, Canada) (n = 20), (3) control, consisting of adjuvant only (AdjuVac) (NWRC) (n = 19) or (4) control, consisting of no injection (n = 18), with every other capture aspect being equivalent. Both GonaCon-B (1000 mg of conjugate) and SpayVac (400 mg of conjugate) were prepared as a water-in-oil emulsion in AdjuVac.
All females were aged by tooth eruption and wear patterns (after Tutt 1968), examined for overall health status and freezebranded for permanent identification on the left side of the rump. In total, 77 females ranging in age from 1 to 20 years were treated systematically over the 2-day period, allowing for random distribution of treatment across all age categories. All horses were immediately released after treatment. In addition to the 77 mares, a small group of females (n = 7) were treated with GonaCon-B (n = 4) or adjuvant only (n = 3) in May of 2005 in a different part of the range. These horses were captured by a feed trap and processed by using the same protocol. They were grouped with the rest of the mares in all of the analyses. All handling and treatment procedures were carried out by and under the supervision of veterinarians from the Nevada Department of Agriculture and were approved by the University of Nevada, Reno Animal Care and Use Committee (Protocol #A06/07-47).
Field observations
We monitored mares from the ground at least weekly to determine fertility rates until December 2008. The treatment group to which each mare belonged was not known to the field observer. Mares were judged fertile if a foal was born at any time during the year or if a female was noticeably pregnant, judged conservatively by an enlarged belly and swollen teats. If females were not seen until after the foaling season and no foal was present, they were recorded as unknown and excluded from the analysis. To examine impacts of contraception on foals, we compared fertile treated mares (contraceptive failures) to control mares. During field observations, we would record the birth of any foal, the sex of the foal and foal survival to weaning.
Faecal sampling and steroid hormone assay
To supplement visual observations, we collected faecal samples opportunistically from August to May yearly to determine pregnancy of mares that may have lost a foal before being visibly pregnant. The behaviour of the horses was monitored throughout the year and when a horse defecated during the observation period, the time and horse identity were recorded. The faecal sample was collected once collection would not disturb the horses. Only samples with 100% certainty of which horse they came from were collected to be as conservative as possible. The number of faecal samples collected from an individual ranged from 1 to 32.
Faecal samples were stored in -20 C freezers until extraction. We used the extraction protocol of Asa et al. (2001) . Samples were thawed and~0.5 g of wet faecal material was placed in a vial with 5 mL of modified phosphate-saline buffer (Shideler et al. 1993) and shaken overnight at room temperature. Samples were centrifuged for 1 h and the supernatant was stored at À80 C until the assay was conducted. The remaining faecal material was dried in a 100 C oven overnight and weighed the next day. Hormone values are based on the dry weight of the faecal samples and are presented as ng g -1 of dried faeces.
Faecal progesterone assays were run at the Saint Louis Zoo and have been used to verify reproductive status of females in many species (Asa et al. 1996 Munson et al. 2001) . We analysed extracted faecal samples for progesterone metabolites with a commercially available radioimmunoassay kit (Progesterone Coat-a-Count, Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA). The progesterone antibody in this kit cross-reacted with multiple progesterone metabolites: progesterone (100%), 17a-hydroxyprogesterone (3.4%), 5apregnan-3,20-dione (9.0%) and 5b-pregnan-3,20-dione (3.2%). We used stripped calf serum to prepare all standards and to dilute all faecal-sample extracts. Faecal samples were run against a calibration curve of progesterone from stripped calf serum. Extraction buffer was added to tubes containing standards and calf serum was added to faecal extracts to equalise the matrices of the samples and standards. All samples, standards and quality controls were run in duplicate.
The inter-assay coefficients of variation were 19%, 23%, 28.5% for low-, medium-and high-quality control standards for seven different assays. The assays were validated for faecal extracts by demonstrating parallelism between serial dilutions of faecal samples (from 1 : 2 to 1 : 16) to the standard curve. The displacement curves were parallel to the standard curve, with correlation coefficients r 2 > 0.99. Recovery of known amounts of hormone added to faecal supernatants (diluted in calf serum) at several different concentrations was 92.3 AE 3%. We biologically verified faecal progesterone samples from 19 mares by comparing their progesterone levels to our observations of their pregnancy and foaling status.
Statistical analysis
We determined the efficacy of contraceptive treatment by comparing the proportion of fertile females in each treatment group with control females across the combined foaling seasons. Females were classified as being either fertile or infertile on the basis of visual monitoring of reproductive status or faecal progesterone levels. If any female was not seen on a regular basis or had no faecal samples collected, they were excluded from the analysis. We used a linear mixed-model analysis with restricted maximum likelihood estimation to determine treatment effects on fertility rates. We used individual identification as a random variable repeated across three foaling seasons. A chisquare test was used to test for differences between foal sex ratios, seasonality of births and foal survival. We defined the foaling season to include April, May and June (Kirkpatrick and Turner 2003) . Results are shown as means AE standard errors where appropriate.
Results
Efficacy
At the time of treatment, there were no differences in the age among all treatment groups (F 3,79 = 0.48, P = 0.694). There was no difference in fertility rates between control mares and adjuvant only mares across the three years (F 1,30 = 0.737, P = 0.397; Table 1 ), and so they were combined for all further analyses. Treatment with contraception significantly reduced fertility for all combined foaling seasons (F 2,72 = 5.811, P = 0.005). Post hoc comparisons revealed that both contraceptive treatments significantly differed from control mares for all foaling seasons combined (GonaCon-B: t 75 = -3.138, P = 0.002, SpayVac: t 68 = -2.314, P = 0.024).
We supplemented fertility data with those from four additional mares that were not seen on a regular basis, but had faecal samples tested for progesterone metabolite levels from October through March. We found two females that were probably not pregnant (both <50 ng g -1 progesterone) and two females that were probably pregnant (both >1800 ng g -1 progesterone) . We confirmed our visual observations of fertility status with faecal progesterone levels in 17 out of 19 mares (control: n = 10; treated: n = 7) from faecal samples that ranged from 8 to 24 samples per female. Pregnant mares had mean faecal progesterone of 2426 AE 228 ng g -1 and non-pregnant females averaged 105 AE 10 ng g -1 . The other two mares, neither of which looked visibly pregnant although they had faecal progesterone levels that indicated pregnancy, were one SpayVac-treated mare that lost her foal between March and April 2006 (likely post partum), and one GonaCon-B-treated mare who lost her foetus in October 2005. The cause of these losses is unknown.
Side effects of treatment
During our monitoring efforts, we found no abscesses or inflammation at the injection sites in the mares observed after treatment. There was no difference in the seasonality of births across the 3 years between these treated mares and controls (c 2 1 = 0.630, P = 0.427), with the majority of all foals being born in April (46%) and May (46%) (Fig. 1) . There was no treatment effect on foal survival (c 2 3 = 0.002, P = 0.969). There was also no difference in the foal sex ratio between treatments across three foaling seasons (c 2 3 = 0.939, P = 0.816), with 48% and 50% of the foals being male in the treated and control mares, respectively.
Discussion
As with many wildlife species, free-living horse populations continue to present a management problem, and past management methods are increasingly unfeasible or ineffective. Consequently, contraceptive treatments have become more widely tested to reduce herd numbers and population growth, especially with the development of a contraceptive agent that provides multi-year contraception after a single dose (Turner et al. 2007; Killian et al. 2008) . We show that free-living horse fertility rates were decreased by contraceptive formulations, with the use of single-injection vaccinations. Both GonaCon-B and SpayVac reduced fertility rates in every foaling season, suggesting that both formulations were successful at preventing pregnancy for multiple years. In addition, both treatments consistently reduced fertility within individual females throughout the 3 years. Our results indicated that long-term contraception of free-roaming horses is possible with both GonaCon-B and SpayVac, providing viable alternatives for long-term population control in feral horses. Furthermore, both GonaCon-B and SpayVac have been shown to be effective in several other wildlife species (Brown et al. 1997; Miller et al. 2000a Miller et al. , 2004 Fraker et al. 2002; Hernandez et al. 2006; Killian et al. 2006; Massei et al. 2008 ). Although we report fertility rates for only 3 years after treatment, we expect, on the basis of our captive trials , that treated mares will continue to be effectively contracepted for the following 2 years and we are continuing to monitor these females for the duration of that time.
Although we found a reduction in fertility, our efficacy was lower than in most previous studies of contraception in free-living horses (Kirkpatrick et al. 1990; Turner et al. , 2007 . Although this may have been due to the treatment method, this seems unlikely because all mares received the full dose while in the squeeze chute. It is likely that in the first foaling season (2006) some mares were already pregnant when we treated them in 2005, thus reducing the appearance of efficacy for the first season because they were already pregnant and these formulations are not supposed to interfere with pregnancy. This would not explain our lower efficacy rates in the second and third season. It is possible that our lower efficacy rates are due to our sampling techniques. We monitored our horses more intensively than in other studies by locating horses at least weekly and used highly conservative estimates of pregnancy and foal production because horses may abort foetuses throughout the year or may lose foals shortly after birth (Keiper and Houpt 1984; Lucas et al. 1991) . If individuals are not closely monitored, these events would be missed and would increase the appearance of contraceptive efficacy and also fertility in control females. In our study, mares that were only seen late in the foaling season without a foal were excluded from the analysis because it was not possible to determine whether they had lost their foal or had not foaled at all. The inclusion of these mares would significantly boost our efficacy rates. This suggests that constant monitoring of individuals may give a more accurate representation of fertility rates. Our lower efficacy rates may have resulted from interindividual differences in responsiveness to the treatment. We noticed that certain mares consistently responded to the treatment, whereas others did not (e.g. they were pregnant or foaled). Variation in response to different contraceptive formulations and adjuvants has been demonstrated Fayrer-Hosken et al. 2002; Frank et al. 2005) , although the cause of that variation has not been investigated. Killian et al. (2008) showed higher efficacy rates in captive feral horses by using the same treatments on the same species from the same population as we studied. The captive mares had a much better response to the treatment and showed higher levels of fertility reduction for the first 2 years after treatment (e.g. 100% and 83% for SpayVac-treated mares and 94% and 60% for GonaCon-treated mares ). We hypothesise that this may be due to differences in condition between captive and wild mares because captive mares are all in good body condition and have access to better-quality nutrition, which may increase immune functioning compared with animals in poor condition (Houston et al. 2007) .
Impacts on foals
Another limitation of contraceptive treatment is the potential for side effects (Nettles 1997) . We investigated how contraceptive treatment could affect foals born to females in which the contraception failed. Feral-horse populations differ in the timing of their birthing season, although the majority of foals are born in the spring (Feist and McCullough 1975; Keiper and Houpt 1984; Berger 1986 ). Foal survival is related to the season of birth, with foals being more likely to survive when they are born in the spring than in the winter. Previous studies have shown that PZP treatments can lead to increased oestrous cycling during the non-breeding seasons (McShea et al. 1997; Miller et al. 2000b; Curtis et al. 2002) . These side effects can result in offspring born out of season leading to reduced survival (e.g. white-tailed deer, McShea et al. 1997 ). Although we found two foals born in July, most foals were born in the spring months of April and May to both treated and control females and this is consistent with other feral-horse populations (Kirkpatrick and Turner 2003) . These data suggest that contraceptive treatment does not significantly affect the timing of foal births or foal survival in feral horses.
Contraceptive treatment has been shown to increase the body condition of mares (Turner and Kirkpatrick 2002) . These changes to body condition can have an impact on the sex of the foal because females that experience an increase in body condition at the time of conception have more males (Cameron and Linklater 2007) . In our study, we found no evidence that the sex ratio of foals changed as a result of a failure of contraceptive treatment. It would be interesting to continue to monitor sex ratios in mares after the contraceptive has ceased to be effective, because mares that have not foaled for several years should be in better body condition (e.g. Turner and Kirkpatrick 2002) , which could lead to an increase in male births (e.g. Monard et al. 1997; Cameron and Linklater 2000, 2007) .
Summary
A current drawback of most contraceptive vaccines is the need for annual inoculations and, therefore, the need for multiple gathers. For many wildlife managers, this issue alone makes contraception an impractical option. Fertility control of pest or invasive species has become increasingly important for management, especially when lethal control is unacceptable or impractical. Our findings demonstrate that new contraceptive formulations are able to reduce fertility in females for several years without the need for boosters. We conclude that these formulations would be useful for managing feral-horse populations, and also other species that require long-term population control because they reduce the costs and stress associated with multiple treatments. We also emphasise the importance of sampling methods when studying efficacy rates in wild populations to get an accurate representation of fertility rates in treated and control individuals.
